Ultra Medica Pharmaceutical Industries / Products

Ultra Medica Pharmaceutical Industries

 


 


 


 


 
 


 


Products » » Musculoskeletal Drugs

Product Search

Drug Index A to Z

Filter:
All 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Orphipal ( Aspirin + Orphenadrine Citrate + Caffeine )

  • Effective Material
    Aspirin 385 mg + Orphenadrine Citrate 25 mg + Caffeine 30 mg
  • Caliber
    385 mg + 25 mg + 30 mg
  • Pharmacologic Form
    - Stimulants
    - Muscarinic antagonist
  • Therapeutic Categories
    Musculoskeletal Drugs
  • Pharmaceutical Form
    Tablets
Composition
Each 1 tablet contains :
385 mg Aspirin
25 mg Orphenadrine Citrate
30 mg Caffeine
Side effect
It may be happen in few cases tachycardia , palpitation , urinary hesitancy or retention , dry mouth, blurred vision , dilatation of the pupil , weakness , nausea headache , dizziness , constipation , drowsiness .
Pharmacodynamics properties
This product contains Orphenadrine citrate which is centrally acting muscle relaxant , his mode of therapeutic action may be related to its analgesic properties and also possesses anticholinergic action , Aspirin which has analgesic and antipyretic action and Caffeine which enhance the analgesic effect to this product .
Therapeutic indications
This product is indicated to :
1- Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders ( low back pain , neck pain . muscle injuries , muscle spasm ).
2- 2The Orphenadrine component is indicated as an adjunct to rest , physical therapy and other measures for the relief of discomfort associated with acute painful musculoskeletal condition .
Contraindication
This product should not be used in patients with glaucoma , pyloric and duodenal obstruction ,achalsia , prostatichypertrophy or obstruction at the bladder neck , myasthenia gravis , patients know to be sensitive to aspirin or caffeine .
Warnings and precautions
Caution should be taken when used this product in patients with chicken pox influenza or flu symptoms , because risk of occurring Reye's syndrome , and while operating machinery or driving a motor vehicle , and in patient , with the presence of peptic ulcers and coagulation abnormalities .
Pregnancy and lactation
Safety of the use of this preparation in pregnancy and during lactation has not been established .
Use of the drug in such patients requires that the potential benefits of the drug be weighed against its possible hazard to the mother and child.
DOSAGE & ADMINISTRATION
As doctor prescribe and it is recommended as : 1 → 2 tablets 3 → 4 times daily .
Package
Box of 20 tablets

Advertising posters of the product

1
2